Document is current
Any future updates will be listed below
-
Authors
Kabeer, Farhia
Tran, Hoa
Andronescu, Mirela
Singh, Gurdeep
Lee, Hakwoo
Salehi, Sohrab
Wang, Beixi
Biele, Justina
Brimhall, Jazmine
Gee, David
Cerda, Viviana
O’Flanagan, Ciara
Algara, Teresa
Kono, Takako
Beatty, Sean
Zaikova, Elena
Lai, Daniel
Lee, Eric
Moore, Richard
Mungall, Andrew J.
,
Williams, Marc J.
Roth, Andrew
Campbell, Kieran R.
Shah, Sohrab P.
Aparicio, Samuel https://orcid.org/0000-0002-0487-9599
-
Funding
Funding for this research was provided by:
Institute of Cancer Research (FDN-148429)
- License Information
-
More Information
Article History
Received: 18 September 2023
Accepted: 20 June 2024
First Online: 18 July 2024
Declarations
:
: The Ethics Committee at the University of British Columbia approved all the experiments using human tissue resources. Patients in Vancouver, British Columbia, were recruited and samples were collected under the tumor tissue repository (TTR-H06-00289) as described [], except Pt6 (SA1035), which was collected under REB-approved protocols at the McGill University Health Centre and Jewish General Hospital as described []. Samples were transplanted to mice under the Animal Resource Centre (ARC) bioethics protocol (A19-0298-A001) approved by the Animal Care Committee (University of British Columbia BC Cancer Research Ethics Board H20-00170) protocols. We can confirm that all experimental methods comply with the Helsinki Declaration.
: Not applicable.
: Samuel Aparicio is founder of Genome Therapeutics Ltd, outside the scope of this study. The remaining authors declare that they have no competing interests.
